Efficacy of asciminib against ABL-rearrangement of Ph-like Acute Lymphoblastic Leukaemia is dependent on the presence of the SH3 domain.

  • Elias Lagonik (Speaker)

Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

Description

PhD Candidate Elias Lagonik, was a top 5 scoring abstracts invited to give an oral presentation in the Presidential Symposium.
Period28 Oct 2024
Event titleBlood 2024: the combined Annual Scientific Meeting of the: Haematology Society of Australia and New Zealand Australian and New Zealand Society of Blood Transfusion Thrombosis and Haemostasis society of Australia and New Zealand
Event typeConference
LocationBrisbane, Australia, QueenslandShow on map

Keywords

  • Aciminib
  • ABL
  • Ph-Like
  • ALL
  • SH3